Auswahl der wissenschaftlichen Literatur zum Thema „IGF Type 2“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "IGF Type 2" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "IGF Type 2"
Hansenne, Isabelle Sylvie, Chantal Renard und Vincent Geenen. „Igf2 expression is required for complete tolerance to insulin (128.19)“. Journal of Immunology 178, Nr. 1_Supplement (01.04.2007): S213—S214. http://dx.doi.org/10.4049/jimmunol.178.supp.128.19.
Der volle Inhalt der QuelleBallard, F. J., M. Ross, F. M. Upton und G. L. Francis. „Specific binding of insulin-like growth factors 1 and 2 to the type 1 and type 2 receptors respectively“. Biochemical Journal 249, Nr. 3 (01.02.1988): 721–26. http://dx.doi.org/10.1042/bj2490721.
Der volle Inhalt der QuelleLouis, Céline, Chantal Renard, Alain Bosseloir, Ilse Weets, Frans Gorus und Vincent Geenen. „Humoral and cellular immune responses to IGF-2 in type 1 diabetes (128.21)“. Journal of Immunology 178, Nr. 1_Supplement (01.04.2007): S214. http://dx.doi.org/10.4049/jimmunol.178.supp.128.21.
Der volle Inhalt der QuelleRosenzweig, Steven A. „The Continuing Evolution of Insulin-like Growth Factor Signaling“. F1000Research 9 (23.03.2020): 205. http://dx.doi.org/10.12688/f1000research.22198.1.
Der volle Inhalt der QuelleAl-janaby, Mohammed Salih, Mohammed Qais Al-ani und Marrib N. Rasheed. „RELATIONSHIP BETWEEN SOME IMMUNOLOGICAL FACTORS AND TYPE 2 DIABETES MELLITUS IN IRAQI PATIENTS“. Asian Journal of Pharmaceutical and Clinical Research 11, Nr. 6 (07.06.2018): 489. http://dx.doi.org/10.22159/ajpcr.2018.v11i6.25881.
Der volle Inhalt der QuelleBallard, F. J., L. C. Read, G. L. Francis, C. J. Bagley und J. C. Wallace. „Binding properties and biological potencies of insulin-like growth factors in L6 myoblasts“. Biochemical Journal 233, Nr. 1 (01.01.1986): 223–30. http://dx.doi.org/10.1042/bj2330223.
Der volle Inhalt der QuelleSchuller, A. G. P., J. W. van Neck, R. W. Beukenholdt, E. C. Zwarthoff und S. L. S. Drop. „IGF, type I IGF receptor and IGF-binding protein mRNA expression in the developing mouse lung“. Journal of Molecular Endocrinology 14, Nr. 3 (Juni 1995): 349–55. http://dx.doi.org/10.1677/jme.0.0140349.
Der volle Inhalt der QuelleWasim, H., M. Abdelmonem, S. Samir und A. Salah. „Monitoring Of IGF-1 Levels In Type 2 Diabetic Patients With Macro And Microvascular Complications“. American Journal of Clinical Pathology 154, Supplement_1 (Oktober 2020): S127—S128. http://dx.doi.org/10.1093/ajcp/aqaa161.279.
Der volle Inhalt der QuelleNarayanan, Ram P., Matthew Gittins, Kirk W. Siddals, Robert L. Oliver, Julie E. Hudson, Anne White, Paul Durrington, Robert R. Davies, Martin K. Rutter und J. Martin Gibson. „Atorvastatin administration is associated with dose-related changes in IGF bioavailability“. European Journal of Endocrinology 168, Nr. 4 (April 2013): 543–48. http://dx.doi.org/10.1530/eje-12-0844.
Der volle Inhalt der QuelleKirk, S. P., M. A. Whittle, J. M. Oldham, P. M. Dobbie und J. J. Bass. „GH regulation of the Type 2 IGF receptor in regenerating skeletal muscle of rats“. Journal of Endocrinology 149, Nr. 1 (April 1996): 81–91. http://dx.doi.org/10.1677/joe.0.1490081.
Der volle Inhalt der QuelleDissertationen zum Thema "IGF Type 2"
Boulle, Nathalie. „Analyse du système des insulin-like growth factors (IGF) et du fibroblast growth factor-2 (FGF-2) dans la tumorigenèse corticosurrenalienne“. Paris 11, 2000. http://www.theses.fr/2000PA11T006.
Der volle Inhalt der QuelleLn adrenocortical tumors, malignant phenotype is associated with abnormalities at the 11p15 locus and overexpression of the IGF-11 gene. Here, we show that IGF-11 mRNA is efficiently translated and that malignant adrenocortical tumors contain large amounts of IGF-11 protein, mainly in its prohormone form. The same tumors exhibit a high content in IGFBP-2 protein, an IGFBP being frequently expressed in tumor cells. The H295R cell line, which is derived from a human adrenal carcinoma, express high levels of both IGF-11 and IGFBP-2 and represents a suitable in vitro model to study adrenocortical tumorigenesis. Using this cell line, we could demonstrate that IGF-11 is involved in the proliferation of adrenocortical tumor cells, after binding to the type 1 IGF receptor. The interest of plasma IGFBP-2 as a marker for adrenocortical carcinoma was evaluated. Our results show that high levels of IGFBP-2 are specifically detected in the plasma of patients with malignant adrenocortical tumors. However, the increase in IGFBP-2 levels occur at a late stage of tumor progression (metastatic stage). This indicates a poor sensitivity for plasma IGFBP-2, which may limit its interest as a tumor marker. We also studied the effects of FGF-2 on adrenocortical tumor cells. Our results indicate that FGF-2 is mitogenic for H295R cells, although it inhibits the expression of both IGF-11 and IGFBP-2 by these cells. The inhibition of IGFBP-2 expression occur at the transcriptional levels. Ln contrast, FGF-2 inhibits the secretion and the last steps of maturation of the IGF-11 precursor. Altogether, these results suggest that in malignant adrenocortical tumors, various factors may modulate the expression (FGF-2) or the effects (IGFBP-2) of IGF-11 on adrenocortical tumor cells
Narayanan, Ram. „Genotype and phenotype interactions of the insulin-like growth factor system in type 2 diabetes“. Thesis, University of Manchester, 2013. https://www.research.manchester.ac.uk/portal/en/theses/genotype-and-phenotype-interactions-of-the-insulinlike-growth-factor-system-in-type-2-diabetes(5e6925fb-195d-47d8-a06d-8957a8f3b86f).html.
Der volle Inhalt der QuelleO'Reilly, Kathryn Elizabeth. „Integration of mtor and IGF-1 signaling : feedback upregulation of survival pathways in human cancer cells /“. Access full-text from WCMC:, 2007. http://proquest.umi.com/pqdweb?did=1296100571&sid=11&Fmt=2&clientId=8424&RQT=309&VName=PQD.
Der volle Inhalt der QuelleTrivedi, Harsha N. „Characterization of type-1/type-2 cytokine and IgE responses of HIV-1 resistant Kenyan women, characterization of neonatal type-1/type-2 cytokine responses“. Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk2/tape17/PQDD_0002/NQ32027.pdf.
Der volle Inhalt der QuelleRøge, Rikke Meldgaard. „Pharmacometric Models of Glucose Homeostasis in Healthy Subjects and Diabetes Patients“. Doctoral thesis, Uppsala universitet, Institutionen för farmaceutisk biovetenskap, 2016. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-274239.
Der volle Inhalt der QuelleGodefroy, Anastasia. „Nouvelle stratégie d'enzymothérapie substitutive ciblant le récepteur du mannose 6-phosphate pour les maladies lysosomales“. Thesis, Montpellier, 2019. http://www.theses.fr/2019MONTT030.
Der volle Inhalt der QuelleLysosomal diseases form a heterogeneous group of about fifty rare diseases. At present, only 9 lysosomal diseases have a specific treatment, mainly by enzyme replacement therapy but the beneficial effects appear often limited. The lack of targeting for the Mannose 6-Phosphate Receptor (M6PR), responsible for internalization into the lysosomes, would partly explain this moderate efficiency of the therapeutic enzymes. In this context, we have developed an innovative targeting approach based on Mannose 6-Phosphate Synthetic Analogues Functionalized at the Aglycone position (called AMFAs) to address the unmet needs of current treatments.The work of this thesis focuses mainly on Pompe disease which is a myopathy caused by the deficiency of a lysosomal enzyme, Acid Alpha Glucosidase (GAA), responsible for the conversion of glycogen into glucose. In order to improve the targeting of the therapeutic enzyme to lysosomes via the M6PR, we have functionalized the human recombinant GAA (rhGAA) with the AMFAs. Our studies on aged mice model of the adult form of the disease have demonstrated a significant increase of the enzyme internalization and for the first time, the restoration of muscle health and the significant improvement in motor function (article 1). We then investigated the properties of rhGAA-AMFA. We have proved that the effectiveness of rhGAA-AMFA is not only due to a better cell uptake but also to a more complete intracellular processing of the enzyme (article 2). Indeed, our results demonstrated that in myoblasts of patients affected by Pompe disease there is an overexpression of ACP2 and ACP5 acid phosphatases. These phosphatases can destroy the mannose 6-phosphate signal (M6P) naturally present on the enzyme, therefore possibly interrupting its processing into the active form. AMFA, unlike M6P, is insensitive to this degradation and thus ensures the stability of enzyme addressing in vitro, but also in vivo.All together, these results suggest that the grafting of the AMFAs on recombinant enzymes represents a new therapeutic solution for the treatment of Pompe disease and potentially for other lysosomal diseases
Fabris, Chiara. „Glucose variability assessment in diabetes mellitus monitoring and control“. Doctoral thesis, Università degli studi di Padova, 2015. http://hdl.handle.net/11577/3424146.
Der volle Inhalt der QuelleL'obiettivo di questa tesi è l'indagine del ruolo della variabilità glicemica (GV) nella patologia del diabete mellito. La GV è un fattore di rischio per lo sviluppo di complicazioni dal diabete, e la sua valutazione combinata con quella dei livelli di emoglobina glicata è ritenuta essere un elemento utile nel caratterizzare il funzionamento del metabolismo del glucosio. Data l'importanza della GV nel diabete, molteplici indicatori che permettono di ottenerne una quantificazione dall'analisi retrospettiva di segnali di self-monitoring of blood glucose (SMBG) o continuous glucose monitoring (CGM) sono stati proposti in letteratura, ma in merito esistono alcune problematiche ancora aperte. Per esempio, alcuni indici sono stati sviluppati specificamente per essere applicati su serie SMBG, ed il loro utilizzo su segnali CGM non è ancora stato validato. Inoltre, il fatto che esistano numerosi indicatori per quanticare la GV dà origine a problemi di ridondanza nell'informazione trasmessa, ed un approccio che permetta di ottenere una descrizione compatta ma esaustiva della GV sarebbe desiderabile. Infine, l'uso di segnali CGM e dell'informazione sulla GV per classificare lo stato metabolico di soggetti normali e diabetici è un problema relativamente inesplorato che potrebbe meritare di essere trattato. Questi tre argomenti sono l'oggetto di questa tesi, che risulta articolata in sei capitoli il cui contenuto è brevemente delineato di seguito. Il Capitolo 1 descriverà l'eziologia dei differenti tipi di diabete, discuterà lo sviluppo delle complicazioni da diabete, ed introdurrà le tecnologie utilizzate per monitorare la glicemia ed alcune strategie che si possono seguire per trattare il diabete mellito di tipo 1 (T1DM) e 2 (T2DM). Il Capitolo 2 verterà sulla GV e la sua quantificazione, e, dopo aver evidenziato i problemi aperti esistenti, dichiarerà precisamente gli scopi della tesi. Il Capitolo 3 considererà il problema di adattare alcuni indicatori di GV originariamente sviluppati e validati su profili SMBG, all'utilizzo su segnali CGM. In particolare, ci concentreremo su low blood glucose index (LBGI) e high blood glucose index (HBGI), indici popolari che permettono di ottenere una rapida classificazione della qualità del controllo glicemico in soggetti diabetici, e forniremo versioni alternative di questi indicatori adattate alle caratteristiche dei segnali CGM, modellando la relazione tra i valori che LBGI e HBGI assumono quando calcolati da SMBG e CGM. Un dataset di 28 soggetti T1DM monitorati con dispositivi SMBG e CGM sarà utilizzato per mettere a punto la metodologia. Il Capitolo 4 affronterà il problema della ridondanza nell'informazione fornita dagli indicatori di GV esistenti, utilizzando la sparse principal component analysis (SPCA) come approccio per fornire una descrizione parsimoniosa ma allo stesso tempo esaustiva della GV in popolazioni di soggetti con T1DM e T2DM. In particolare, considereremo 25 indicatori di GV valutati su profili CGM acquisiti da 33 soggetti con T1DM e 13 con T2DM come insieme iniziale di variabili. La SPCA sarà applicata a questo pool di indici e permetterà di selezionare un piccolo sottoinsieme di 10 indicatori che consente di preservare più del 60% della varianza originariamente spiegata dall'insieme di partenza in entrambe le applicazioni. Il sottoinsieme di indicatori fornito dalla SPCA può essere utilizzato per descrivere parsimoniosamente la GV nel diabete. Il Capitolo 5 sarà dedicato alla valutazione della possibilità di utilizzare gli output della SPCA per costruire classificatori dello stato metabolico di soggetti normali e diabetici basati sulla GV. In particolare, facendo ricorso ad un dataset di 55 soggetti con T1DM, 34 normali a rischio T2DM, 39 con impaired glucose tolerance, e 29 con T2DM diagnosticato, mostreremo che classificatori progettati su support vector machine sono capaci di discriminare con successo la qualità del controllo glicemico e la condizione metabolica di soggetti con disordini, permettendo di raggiungere un'accuratezza di classicazione sempre maggiore del 70%. Lo studio sarà condotto utilizzando sia il pool iniziale di 25 indicatori che il sottoinsieme parsimonioso fornito dalla SPCA come features per costruire i classificatori; il fatto che risultati simili siano ottenuti nei due casi rafforza la speculazione che la descrizione compatta della GV fornita dalla SPCA sia effettivamente esaustiva nel caratterizzare la condizione metabolica dei soggetti. Il Capitolo 6 chiuderà la tesi, con una discussione su possibili sviluppi futuri degli studi qui presentati.
Sjöblom, Johan, und Ulrik Malmberg. „Vägen till hälsa : Motivation till fysisk aktivitet hos patienter med förstadie till eller diagnostiserad diabetes typ 2“. Thesis, Högskolan i Borås, Institutionen för Vårdvetenskap, 2012. http://urn.kb.se/resolve?urn=urn:nbn:se:hb:diva-16544.
Der volle Inhalt der QuelleProgram: Sjuksköterskeutbildning
Kondo, Yaeko. „The study of plasma glucose level and insulin secretion capacity after glucose load in Japanese“. Kyoto University, 2016. http://hdl.handle.net/2433/215958.
Der volle Inhalt der QuelleToušková, Věra. „Úloha komponent osy GH/IGF-1 v etiopatogeneze metabolických odchylek u diabetes mellitus 2. typu a akromegalie“. Doctoral thesis, 2016. http://www.nusl.cz/ntk/nusl-265165.
Der volle Inhalt der QuelleBücher zum Thema "IGF Type 2"
name, No. Diabetes sourcebook: Basic consumer health information about type 1 diabetes (insulin-dependent or juvenile-onset diabetes), type 2 diabetes (noninsulin-dependent or adult-onset diabetes), gestational diabetes, impaired glucose tolerance (IGT) ... 3. Aufl. Detroit, MI: Omnigraphics, 2003.
Den vollen Inhalt der Quelle findenD, Matthews Dawn, Hrsg. Diabetes sourcebook: Basic consumer health information about Type 1 diabetes (insulin-dependent or juvenile-onset diabetes), Type 2 diabetes (noninsulin-dependent or adult-onset diabetes, gestational diabetes, impaired glucose tolerance (IGT), and related complications, such as amputation, eye disease, gum disease, nerve damage, and end-stage renal disease : including facts about insulin, oral diabetes medications, blood sugar testing, and the role of exercise and nutrition in the control of diabetes : along with a glossary and resources for further help and information. 3. Aufl. Detroit, Mich: Omnigraphics, 2003.
Den vollen Inhalt der Quelle findenType 2 Diabetes. Exon Publications, 2024. http://dx.doi.org/10.36255/type-2-diabetes.
Der volle Inhalt der QuelleM¨uhlherr, Bernhard, Holger P. Petersson und Richard M. Weiss. Unramified Quadrangles of Type E6, E7 and E8. Princeton University Press, 2017. http://dx.doi.org/10.23943/princeton/9780691166902.003.0011.
Der volle Inhalt der QuelleM¨uhlherr, Bernhard, Holger P. Petersson und Richard M. Weiss. Quadratic Forms of Type F4. Princeton University Press, 2017. http://dx.doi.org/10.23943/princeton/9780691166902.003.0009.
Der volle Inhalt der QuelleM¨uhlherr, Bernhard, Holger P. Petersson und Richard M. Weiss. Semi-ramified Quadrangles of Type E6, E7 and E8. Princeton University Press, 2017. http://dx.doi.org/10.23943/princeton/9780691166902.003.0012.
Der volle Inhalt der QuelleFabrizi, Fabrizio, und Patrice Cacoub. The patient with cryoglobulinaemia. Herausgegeben von Giuseppe Remuzzi. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199592548.003.0151.
Der volle Inhalt der QuelleOkasha, Samir. Agential Thinking and its Rationale. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780198815082.003.0002.
Der volle Inhalt der QuelleHedley, Steve, und Nicola Padfield. 2. Deliberate harm to the person. Oxford University Press, 2013. http://dx.doi.org/10.1093/he/9780199586561.003.0188.
Der volle Inhalt der QuelleKatz, David L. The Integrative Preventive Medicine Approach to Obesity and Diabetes. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190241254.003.0018.
Der volle Inhalt der QuelleBuchteile zum Thema "IGF Type 2"
Nissley, S. Peter. „Type 2 IGF Receptor-Mediated Events“. In The IGF System, 165–97. Totowa, NJ: Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-712-3_8.
Der volle Inhalt der QuelleMoses, Alan C. „Insulin Resistance and Type 2 Diabetes mellitus: Is There a Therapeutic Role for IGF-1?“ In IGF-I and IGF Binding Proteins, 121–34. Basel: KARGER, 2005. http://dx.doi.org/10.1159/000085762.
Der volle Inhalt der QuelleSandhu, Manjinder S. „Insulin-Like Growth Factor-I and Risk of Type 2 Diabetes and Coronary Heart Disease: Molecular Epidemiology“. In IGF-I and IGF Binding Proteins, 44–54. Basel: KARGER, 2005. http://dx.doi.org/10.1159/000085755.
Der volle Inhalt der QuelleFayette, J., B. Fleury und J. Y. Blay. „Nouvelles approches dans les thérapeutiques ciblées: les récepteurs des facteurs de croissance de type insuline (IGF) et les cyclines“. In Les thérapies ciblées, 157–68. Paris: Springer Paris, 2008. http://dx.doi.org/10.1007/978-2-287-36008-4_11.
Der volle Inhalt der QuelleChiasson, Jean-Louis, Markku Laakso und Markolf Hanefeld. „Decreasing Postprandial Plasma Glucose Using an α-Glucosidase Inhibitor in Subjects with IGT for the Prevention of Type 2 Diabetes Mellitus: The STOP-NIDDM Trial“. In Prevention of Type 2 Diabetes, 167–87. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4614-3314-9_10.
Der volle Inhalt der QuelleCascieri, Margaret A., Gary G. Chicchi, Barbara G. Green, Joy Applebaum, Nancy S. Hayes und Marvin L. Bayne. „Analysis of the interaction of IGF I and structural mutants of IGF I with the IGF types 1 and 2 and insulin receptors“. In Peptides, 570–71. Dordrecht: Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-010-9595-2_170.
Der volle Inhalt der QuelleRizqoh, Debie, Kristin Ronaniou Haloho, Enny Nugraheni, Widyawati, Utari Hartati und Riry Ambarsary. „The Influence of Type 2 Diabetes Mellitus Comorbidity Factors in COVID-19 Patients on IgM and IgG Antibody Levels of SARS-Cov-2 at M. Yunus Hospital and Harapan Dan Doa Hospital Bengkulu City“. In Proceedings of the International Conference On Multidisciplinary Studies (ICOMSI 2022), 17–24. Paris: Atlantis Press SARL, 2023. http://dx.doi.org/10.2991/978-2-38476-072-5_3.
Der volle Inhalt der QuelleAllais, Guillaume. „Builtin Types Viewed as Inductive Families“. In Programming Languages and Systems, 113–39. Cham: Springer Nature Switzerland, 2023. http://dx.doi.org/10.1007/978-3-031-30044-8_5.
Der volle Inhalt der QuelleAskenase, Philip W. „Delayed-Type Hypersensitivity Recruitment of T Cell Subsets via Antigen-Specific Non-IgE Factors or IgE Antibodies: Relevance to Asthma, Autoimmunity and Immune Responses to Tumors and Parasites (Part 2 of 2)“. In Regulation and Functional Significance of T-Cell Subsets, 189–212. Basel: KARGER, 1992. http://dx.doi.org/10.1159/000319122.
Der volle Inhalt der QuelleAbdrabo, Karim I., Sameh A. Kantosh, Mohamed Saber, Tetsuya Sumi, Dina Elleithy, Omar M. Habiba und Bahaa Alboshy. „The Role of Urban Planning and Landscape Tools Concerning Flash Flood Risk Reduction Within Arid and Semiarid Regions“. In Natural Disaster Science and Mitigation Engineering: DPRI reports, 283–316. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-16-2904-4_11.
Der volle Inhalt der QuelleKonferenzberichte zum Thema "IGF Type 2"
Zanarel, Palomali, Marina Grigoli, Danielle de Oliveira, Patrícia Manzine und Márcia Cominetti. „IFG-1 PLASMA LEVELS ARE ALTERED IN PATIENTS WITH ALZHEIMER’S DIASEASE AND DIABTES MELLITUS TYPE 2“. In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda045.
Der volle Inhalt der QuelleBid, Hemant K., Doris Phelps und Peter J. Houghton. „Abstract 3277: Insulin-like growth factor-2 (IGF-2) circumvents the antiangiogenic activity of SCH717454, a human antibody that blocks ligand binding to the Type 1 insulin-like growth factor receptor (IGF-1R)“. In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3277.
Der volle Inhalt der QuelleSetiawati, Yessy, Aswiyanti Asri und Rosfita Rasyid. „IGF-1R Expression has More Potential Proliferation Effect in Invasive Breast Carcinoma Of No Special Type Compared to HER-2 Expression“. In Proceedings of the 1st EAI International Conference on Medical And Health Research, ICoMHER November 13-14th 2018, Padang, West Sumatera, Indonesia. EAI, 2019. http://dx.doi.org/10.4108/eai.13-11-2018.2283795.
Der volle Inhalt der QuelleSilva, Bruno Vinícius Diniz e., Brunna Rodrigues de Oliveira, Larissa Silva Magalhães, Kamila Cardoso dos Santos, Livia Melo Vilar, Vanessa Salete de Paula, Karlla Antonieta Amorim Caetano, Sheila Araújo Teles und Megmar Aparecida dos Santos Carneiro. „Seroepidemiological study of herpes simplex virus type 2 (HSV-2) infection in transgender women in Goiás“. In XIII Congresso da Sociedade Brasileira de DST - IX Congresso Brasileiro de AIDS - IV Congresso Latino Americano de IST/HIV/AIDS. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/dst-2177-8264-202133p058.
Der volle Inhalt der QuelleGaffney, P. J., L. J. Creighton, A. Curry, B. MacMahon und R. Thorpe. „MONOCLONAL ANTIBODIES OF THE IgM AND IgG CLASS SPECIFIC FOR CROSSLINKED FIBRIN DEGRADATION PRODUCTS“. In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643651.
Der volle Inhalt der QuellePicó, M., A. Ribera, C. Martin, J. Zuazu und J. Monasterio. „GLANZMANN'S THROMBASTHENIA IN PREGNANCY: CLINICAL FEATURES AND PLATELET SEROLOGY“. In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644556.
Der volle Inhalt der QuelleGardner, R., T. Moran und C. E. Loughlin. „Probable Follicular Bronchiolitis in Pediatric Patient with Hyper IgM Type 2 Syndrome“. In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a7181.
Der volle Inhalt der QuelleStörkel, F., I. Scharrer, L. Hovy, J. Rüdigier und S. Störkel. „HAEMOPHILIC ARTHROPATHY: IMMUNOLOGICAL MECHANISMS AND SYNOVITIS“. In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644023.
Der volle Inhalt der QuelleFuqun, Chen, Li Wenlan, Wang Zongyuan und Cong Mengzi. „An Experimental Investigation of Response of a Turbojet Engine to Inlet Distortion“. In ASME 1985 Beijing International Gas Turbine Symposium and Exposition. American Society of Mechanical Engineers, 1985. http://dx.doi.org/10.1115/85-igt-12.
Der volle Inhalt der QuelleKazama, M., H. Ishii, J. Tsubouchi, M. Nakano, N. Hiramoto, T. Abe und P. W. Majerus. „PREPARATION OF ANTI-HUMAN THROMBOMODULIN ANTIBODIES AND THEIR APPLICATION FOR STUDY ON PLASMA THROMBOMODULIN“. In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643962.
Der volle Inhalt der QuelleBerichte der Organisationen zum Thema "IGF Type 2"
Funkenstein, Bruria, und Cunming Duan. GH-IGF Axis in Sparus aurata: Possible Applications to Genetic Selection. United States Department of Agriculture, November 2000. http://dx.doi.org/10.32747/2000.7580665.bard.
Der volle Inhalt der QuelleWilliams, Thomas. Microbial Mating-type Matching memory Game. University of Dundee, 2023. http://dx.doi.org/10.20933/100001286.
Der volle Inhalt der QuelleMeidan, Rina, und Robert Milvae. Regulation of Bovine Corpus Luteum Function. United States Department of Agriculture, März 1995. http://dx.doi.org/10.32747/1995.7604935.bard.
Der volle Inhalt der QuelleSchick-Makaroff, Kara, Antoinette Davey, Mirjam Sprangers, Veronique Sébille, Rick Sawatzky und Response Shift in Sync Working Group. Protocol for a qualitative metasynthesis on response shift. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Februar 2023. http://dx.doi.org/10.37766/inplasy2023.2.0111.
Der volle Inhalt der QuelleAn, Dayoung, und Seung-ho Sun. The Effect of laser therapy in treating post-stroke shoulder pain: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Januar 2023. http://dx.doi.org/10.37766/inplasy2023.1.0085.
Der volle Inhalt der QuelleAndrian, Leandro Gaston, Oscar Valencia, Jorge Hirs und Ivan Leonardo Urrea Rios. Fiscal Rules and Economic Cycles: Quality (Always) Matters. Inter-American Development Bank, Januar 2023. http://dx.doi.org/10.18235/0004570.
Der volle Inhalt der QuelleLyons, Nicole, Ali Siddiqui, Oluwatunmininu Anwoju, Brianna Cohen, Walter Ramsey, Christopher O'Neil, Zuhair Ali und Mike Liang. Biologic versus Synthetic Mesh for Ventral Hernia Repair: a protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Oktober 2022. http://dx.doi.org/10.37766/inplasy2022.10.0016.
Der volle Inhalt der QuelleShi, Min, Yao Yao, Haifeng Ding, Jian Yang, Zhen Feng, Yingying Jiang und Tao Guo. The Pharyngeal Packs for Dental and Otolaryngological Surgery: A Meta-analysis of High-quality RCTs. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Februar 2023. http://dx.doi.org/10.37766/inplasy2023.2.0002.
Der volle Inhalt der QuelleChust-Hernández, Pablo, Emelina López-González und Joan Maria Senent-Sánchez. Effectiveness of non-pharmacological treatments for academic stress in university students: a protocol for a systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Juli 2022. http://dx.doi.org/10.37766/inplasy2022.7.0071.
Der volle Inhalt der QuelleZheng, You-you, Ning Liang, Long-kun Liu, Wei-jia Sun, Xue-hui Wang, Yu-xin Sun, Yun-ru Chen, Xiao-xia Han, Zhao-lan Liu und Jian-ping Liu. Effectiveness and Safety of Chinese Patent Medicine for Functional Constipation: A Systematic Review and Network-Meta Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, Mai 2022. http://dx.doi.org/10.37766/inplasy2022.5.0049.
Der volle Inhalt der Quelle